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MicroRNA-122 (miR-122) plays a key role in hepatitis C virus 
(HCV) replication, but understand-
ing exactly how it functions in the viral 
lifecycle has been elusive. HCV is a pos-
itive-strand virus with a messenger-sense 
RNA genome, to which miR-122 binds 
in a non-canonical fashion at two sites 
near the 5' end. Recent studies show that 
miR-122 recruits Ago-2 to the genomic 
RNA, stabilizing it and slowing its decay 
in infected cells. This led us to investi-
gate decay pathways that mediate deg-
radation of the viral RNA. We found 
HCV RNA is degraded primarily by 
the cytoplasmic 5' exonuclease Xrn1 in 
infected cells. miR-122 lost its stabiliz-
ing effect when cells were depleted of 
Xrn1 using an RNAi strategy, providing 
strong evidence that miR-122 acts to pro-
tect the viral RNA from Xrn1-mediated 
5' exonucleolytic decay. However, Xrn1 
depletion did not rescue replication of a 
viral mutant defective in miR-122 bind-
ing, indicating that there is much more 
to miR-122’s actions than prevention of 
Xrn1 decay. Here, we consider the role 
of miR-122 in the viral lifecycle, and 
explore the possibility that it might func-
tion directly in viral RNA synthesis.
Introduction
Hepatitis C virus (HCV) is a common 
cause of chronic liver disease and closely 
associated with the development of hepa-
tocellular carcinoma. Classified within 
the Flaviviridae family of viruses, it has 
a single-stranded, messenger-sense RNA 
genome approximately 9.7 kb in length 
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that contains a single, large open reading 
frame encoding a polyprotein under cap-
independent translational control of an 
internal ribosome entry site (IRES).1 The 
replication of this viral RNA is uniquely 
dependent on a host-factor microRNA 
(miRNA), miR-122.2 miR-122 acts 
directly on the viral RNA, and not indi-
rectly through its effects on hepatocellular 
metabolism.3 The critical role it plays in 
the HCV lifecycle is well documented by 
dose-dependent reductions in circulating 
HCV RNA following intravenous admin-
istration of a locked nucleic acid (LNA) 
antisense miR-122 “antagomir” to HCV-
infected chimpanzees and humans.4,5
miRNAs are ~22 nt long RNA 
duplexes that regulate gene expression 
post-transcriptionally, typically by bind-
ing to the 3' untranslated region (3'UTR) 
of mRNAs, repressing their translation 
and mediating their degradation.6,7 miR-
122 is liver-specific and accounts for a 
large proportion of the mature miRNAs 
in hepatocytes,8 the cell targeted for infec-
tion by HCV. miR-122 binds to HCV 
RNA at two conserved sites (S1 and S2) 
within its 5'UTR, immediately upstream 
of the IRES (Fig. 1).9 Binding at both sites 
is important for fulfillment of the virus 
lifecycle and production of infectious 
virus,10 and involves both typical miRNA 
“seed” sequence interactions as well as 
supplemental base-pairing of 3' miRNA 
bases.11-13 Similar to conventional miRNA 
action, miR-122 recruits Argonaute 2 pro-
tein (Ago2) to the viral RNA.14 However, 
in contrast to typical miRNA action, this 
stabilizes HCV RNA and slows its decay 
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synthesis compete with each other to 
determine HCV RNA abundance in cells. 
However, others have reported that Xrn1 
depletion has no positive effects on HCV 
replication.25-27 This discrepancy could be 
due to different experimental systems, or 
possibly varied degrees of cellular toxicity 
accompanying Xrn1 depletion.
miR-122 functions beyond protecting 
HCV RNA. Viral RNAs with mutations 
in the S1 and S2 miR-122-binding sites 
fail to replicate,2,10 further demonstrating 
the importance of miR-122 in the viral 
lifecycle. If miR-122 acts only to protect 
the 5' end of HCV RNA from exonu-
cleolytic degradation, such RNAs might 
be expected to replicate in Xrn1-depleted 
cells. However, we found that near-com-
plete depletion of Xrn1 in Huh-7.5 cells 
(conditions under which miR-122 shows 
no stabilizing effects on the viral RNA) 
failed to rescue the replication of HCV 
RNA containing single-base substitutions 
in both S1 and S2 that ablate miR-122 
binding.20 Supplementing the cells with a 
miR-122 mutant containing complemen-
tary substitutions that restored base-pair-
ing with the mutated viral RNA resulted 
in robust genome amplification. This key 
experiment shows that miR-122 has an 
additional, essential function in HCV 
replication beyond simply protecting the 
RNA genome from Xrn1-mediated degra-
dation. Mortimer and Doudna28 reached 
a similar conclusion in a subsequent 
report describing the effects of miR-122 
on Xrn1-mediated HCV RNA decay in a 
cell-free system.
What might that additional func-
tion of miR-122 be? Early data indicate 
that miR-122 promotes the amplifica-
tion of subgenomic HCV replicons and, 
thus, functions independently of viral 
entry, assembly and release.2 On the 
other hand, miR-122 supplementation 
promotes protein expression from the 
HCV genome,10,29,30 and this has been 
interpreted as suggesting that it might 
enhance IRES-directed translation. The 
effect is about 2-fold, but we believe it 
is likely due to increased RNA stabil-
ity.14 Using a cell-free system, Henke et 
al.29 found that single-stranded miR-
122 promoted translation of a lucifer-
ase reporter RNA containing HCV 5' 
and 3' UTRs.29,31 However, since duplex 
Xrn1 slowed the decay rate to a similar 
extent, while depletion of PM/Scl-100, a 
component of the exosome complex, was 
without effect. Importantly, the stabiliz-
ing effects of miR-122 supplementation 
and Xrn1 depletion were not additive: 
miR-122 supplementation resulted in no 
additional stabilization of the viral RNA 
in Xrn1-depleted cells.20 This provides 
strong evidence that miR-122 stabilizes 
the viral RNA by antagonizing Xrn1-
mediated degradation.
To confirm that 5' degradation is the 
major pathway for decay of HCV RNA, 
we used circularization RT-PCR to iden-
tify RNAs that were partially degraded 
from either end. We found that intact 
HCV RNA could not be ligated (circu-
larized) with T4 RNA ligase unless first 
treated with RNA polyphosphatase.20 
This is consistent with the presence of a 
5' triphosphate, as this would prevent liga-
tion.22 However, degradation intermedi-
ates were ligated without polyphosphatase 
treatment, allowing them to be amplified 
and cloned from cells persistently infected 
with HCV. Almost all of these interme-
diates contained 5' truncations, while the 
3' ends were intact, suggesting that HCV 
RNA is predominantly degraded from its 
5' end.20 Interestingly, the point of trun-
cation within the 5' end was not random, 
suggesting the influence of higher order 
structure or perhaps protein binding. 
These data provide further evidence that 
Xrn1 is responsible for HCV RNA decay 
within infected cells. Since the 5' triphos-
phate must be removed before Xrn1 can 
degrade the RNA body, a cellular phos-
phatase/pyrophosphatase must also be 
involved. The miR-122/Ago2 complex 
could function to protect the 5' triphos-
phate from this putative enzymatic activ-
ity, or from Xrn1 itself. Additional efforts 
will be needed to elucidate the detailed 
mechanism of HCV degradation.
Consistent with Xrn1 being primar-
ily responsible for degradation of HCV 
RNA in infected cells, we found that 
Xrn1 depletion enhances both viral RNA 
abundance and production of infectious 
virus.20 This is in agreement with previ-
ous reports by Jones et al.23 and Ruggieri 
et al.24 that identified Xrn1 as an HCV 
restriction factor, and suggests that Xrn1-
mediated degradation and HCV RNA 
by the miR-122/Ago2 complex can be 
substituted functionally by addition of a 
5' cap, suggesting that it protects against 
5'exonuclease-mediated decay.14
Compared with cellular mRNA decay 
pathways, relatively little is known about 
the degradation of viral RNAs. As the pos-
itive-strand RNA of HCV serves directly 
as mRNA for viral protein translation, we 
considered HCV RNA likely to be subject 
to cellular mRNA decay pathways. The 
degradation of mRNAs typically initiates 
with removal of the 3' poly-(A) tail and/
or 5' cap by deadenylation and decap-
ping enzymes, followed by exonucleo-
lytic degradation of the RNA body.15 The 
cytoplasmic 5' exonuclease Xrn1 and 3' 
exonuclease exosome complex are the two 
major exonucleases involved in this pro-
cess.16,17 HCV RNA is generally consid-
ered to possess a free 5' triphosphate, since 
it is sensed by the innate immune receptor 
RIG-I, and terminates in a 3' stem-loop 
rather than a poly(A) tail. Therefore, nei-
ther deadenylation nor decapping would 
be required for HCV RNA decay, while 
either of the two exonuclease pathways 
could mediate its degradation.
Differential involvement of exonucle-
ases in HCV RNA decay. We have used 
a relatively simple system to investigate 
HCV RNA decay in infected cells.14 Huh-
7.5 cells are derived from a human hepa-
tocellular carcinoma, express a moderate 
abundance of miR-122 and support the 
growth of selected strains of HCV. Huh-
7.5 cells that were stably infected with a 
cell culture-adapted genotype 1a virus 
(H77S.3)18 were treated with a potent 
and selective small-molecule inhibi-
tor of the viral NS5B RNA polymerase, 
PSI-6130 (β-D-2'-deoxy-2'-fluoro-2'-C-
methylcytidine).19 This effectively arrests 
new viral RNA synthesis, and allowed 
us to assess the rate of decay of the viral 
RNA by real-time qRT-PCR. The rate of 
decay is much slower under these condi-
tions than when synthetic RNA is electro-
porated into cells (t
½
 of ~11 h vs. 1.4 h),20 
most likely because the replicating RNA is 
sequestered within membranous vesicles.21 
Supplementing the cells with additional 
miR-122 by transfecting synthetic duplex 
miRNA significantly increased the half-
life of the viral RNA (t
½
 ~18 h).14,20 siRNA-
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binds to a stem-loop that lies within the 
S1 miR-122 binding site in the HCV posi-
tive-strand (Fig. 1).36,37 Thus, it could play 
a similar role, but on the opposing strand 
and in concert with miR-122, during 
HCV replication. These two hypothetical 
mechanisms are not mutually exclusive, 
and either or both could explain how miR-
122 contributes to genome amplification.
These models raise a number of ques-
tions that have yet to be answered. First, 
does miR-122 remain bound to the viral 
RNA during later steps in the virus life-
cycle, such as assembly and packaging of 
the genome? Is it present within extra-
cellular virions? Also, are there proteins 
other than Ago2 that act as co-factors 
in miR-122 promotion of virus replica-
tion? Although Ago2 is essential for the 
actions of miR-122 on HCV RNA, this is 
not the case with Dicer, also a component 
of the RNA-induced silencing complex 
(RISC).14,30,38 Depleting cells of TRBP 
(transactivating response RNA-binding 
protein) or DDX6 (Rck/p54), both of 
which are involved in cellular miRNA 
function, may slow HCV replication, but 
neither is required for miR-122 to stimu-
late it.38,39 Thus, it seems that miR-122 
requires only a subset of the host proteins 
required for cellular miRNA function, 
and perhaps only Ago2, in order to sup-
port HCV replication.
Apart from a specific function in RNA 
replication, miR-122 could help to mask 
the viral RNA from pathogen-recogni-
tion receptors, such as RIG-I (DDX58) 
and IFITs (interferon-induced protein 
with tetratricopeptide repeats) that sense 
positive-strand RNA acts as a promoter 
for the viral RNA-dependent RNA poly-
merase that binds it and, through a long-
range interaction involving cyclization of 
the dengue genome, initiates minus-strand 
RNA synthesis at its 3' end.33 The RNA 
structure formed by miR-122 interactions 
with the HCV 5'UTR could act in a simi-
lar fashion (Fig. 2A). Alternatively, miR-
122 might function during a subsequent 
step in the replication cycle. Completion 
of negative-strand synthesis likely results 
in a genome-length duplex referred to as 
“replicative form” RNA (RF). The synthe-
sis of new positive-strand RNA then initi-
ates at the 3' end of the negative-strand of 
the RF, which must first dissociate from 
the positive-strand to allow interactions 
with the polymerase. This is a thermody-
namic problem common to all positive-
strand RNA viruses. Despite absolute 
complementarity, it is likely that the RF 
termini “breath” to some extent, and that 
the strand separation required for posi-
tive-strand synthesis would be favored by 
stable secondary structure or protein bind-
ing at the end of either strand.34,35 miR-
122, together with the protein factor(s) it 
recruits, could promote strand separation 
by binding the 5' end of the RF positive-
strand. This would free the 3' end of the 
negative-strand, allowing for interactions 
with the polymerase and initiation of pos-
itive-strand synthesis (Fig. 2B). Poly(rC)-
binding protein 2 (PCPB2) is thought to 
facilitate strand-separation during polio-
virus replication by binding both ends of 
negative-strand RNA and promoting its 
circularization.34 Interestingly, PCPB2 
miR-122 is required for genome amplifi-
cation,14 this is likely to be an artifact of 
the cell-free setting. Roberts et al.12 also 
reported that miR-122 enhanced transla-
tion of similar reporter RNAs in trans-
fected cells. Although this was dependent 
upon the HCV IRES and not observed 
with similar reporter RNAs contain-
ing IRES sequences from other viruses, 
it is not clear that these observations 
can be extrapolated to genome-length 
HCV RNA. We found miR-122 bind-
ing is not required for ribosomes to load 
onto HCV RNA.20 We also observed no 
increase in viral protein expression when 
cells depleted of Xrn1 were treated with 
PSI-6130 (arresting viral RNA synthe-
sis) and simultaneously supplemented 
with miR-122.20 Collectively, these data 
argue strongly against miR-122 enhanc-
ing IRES-directed translation initiation.
Could miR-122 function directly in 
viral RNA synthesis? Norman et al.3 
demonstrated a decrease in 4-thiouridine-
labeled HCV RNA synthesis in cells 
pulsed 6–7 h after transfection of an LNA 
anti-miR-122 antagomir. However, total 
HCV RNA was also decreased, and the 
amount of newly synthesized RNA was 
in fact slightly increased relative to total 
RNA. While elegant, this experiment is 
difficult to interpret due to the uncertain 
effects of miR-122 on stability of RNA 
pools within and outside of replication 
complexes. Other evidence comes from 
studies in which we found the addition of 
miR-122 or anti-miR-122 had no effect 
on ex vivo synthesis of HCV by isolated 
membrane-bound replicase complexes.32 
This experiment reflects only the elonga-
tion phase of viral RNA synthesis, how-
ever, and unlike the situation in vivo, the 
isolated replicase complexes are likely to be 
sealed membrane-bound compartments 
allowing only limited access of miR-122. 
We do not think that either of these obser-
vations excludes a direct role for miR-122 
in viral RNA synthesis, particularly dur-
ing initiation.
Current understanding of how HCV 
replicates its genome is incomplete, but 
miR-122 can be envisioned to contribute 
functionally to the initiation of RNA syn-
thesis in at least two ways. During replica-
tion of the distantly related dengue virus, 
a complex stem-loop at the 5' end of the 
Figure 1. two copies of miR-122 (red font) bind the extreme 5' end of the positive-strand RNA 
genome of HCV (black font). the base-pair interactions shown have been established by genetic 
approaches and are important for viral replication. Seed sequence interactions are labeled S1 and 
S2. miR-122 recruits Ago2 to the RNA. PCPB2 binds to stem-loop 1 of the viral 5' NtR, formed by 
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RNAs with free 5' triphosphates and are 
important anti-viral factors.40,41 In this 
way, miR-122 could function to diminish 
innate anti-viral defenses against HCV. 
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negative-strand or (B) positive-strand HCV RNA synthesis. Positive-strand (genome sense) RNA is 
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